These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6714294)

  • 1. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
    Arndts D; Arndts K
    Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
    Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal and oral clonidine.
    Lilja M; Juustila H; Sarna S; Jounela AJ
    Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
    Ambrosioni E
    Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and side-effects of clonidine.
    Keränen A; Nykänen S; Taskinen J
    Eur J Clin Pharmacol; 1978 May; 13(2):97-101. PubMed ID: 658114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the antihypertensive effect of TTS clonidine by multiple 24-hour automatic blood pressure monitoring.
    Mancia G; Parati G; Pomidossi G; Malaspina D; Colombo A; Camesasca C; Groppelli A; Casadei R; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S187-93. PubMed ID: 2455177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
    Kellaway GS; Lubbe WF
    N Z Med J; 1986 Sep; 99(810):711-4. PubMed ID: 3547202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ; Johnson KL; McConnell J
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro/in vivo functionality of Catapres-TTS.
    Enscore DJ; Osborne JL; Shaw JE
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal clonidine for hypertensive patients.
    Popli S; Stroka G; Ing TS; Daugirdas JT; Norusis MJ; Hano JE; Gandhi VC
    Clin Ther; 1983; 5(6):624-8. PubMed ID: 6627288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
    Chen SW; Vidt DG
    Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of transdermally delivered clonidine.
    MacGregor TR; Matzek KM; Keirns JJ; van Wayjen RG; van den Ende A; van Tol RG
    Clin Pharmacol Ther; 1985 Sep; 38(3):278-84. PubMed ID: 4028622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system.
    Weber MA; Drayer JI
    Am Heart J; 1984 Jul; 108(1):231-6. PubMed ID: 6375331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.
    Davies DS; Wing AM; Reid JL; Neill DM; Tippett P; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):593-601. PubMed ID: 870272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine.
    Harron DW; Arndts D; Finch M; Shanks RG
    Br J Clin Pharmacol; 1983 Oct; 16(4):451-5. PubMed ID: 6626441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values.
    Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR
    JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man.
    Arndts D; Doevendans J; Kirsten R; Heintz B
    Eur J Clin Pharmacol; 1983; 24(1):21-30. PubMed ID: 6832197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.